[1]Aggarwal S, Ghilardi N,Xie MH,et a1.Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.J Biol Chem,2003,278 (3):1910-1914. [2]Maddur MS, Miossec P, Kaveri SV, et al. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol, 2012, 181(1):8-18. [3]Ghoreschi K, Laurence A, Yang XP, et al. Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature, 2010, 467 (7318):967-971. [4]El-Behi M, Ciric B, Dai H, et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol, 2011,12(6):568-575. [5]Lockhart E,Green AM,Flynn JL. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection.J lmmunol, 2006, 177 (7):4662-4669. [6]Umemura M,Yahagi A,Hamada S,et a1.IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection.J Immunol, 2007,178 (6):3786-3796. [7]Okamoto Yoshida Y, Umemura M, Yahagi A, et al. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J Immunol, 2010,184(8):4414-4422. [8]Jurado JO, Pasquinelli V, Alvarez IB, et al. IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease. J Leukoc Biol, 2012,91 (6):991-1002. [9]Lin Y, Ritchea S, Logar A, et al. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity, 2009,31(5):799-810. [10]Muoz S, Rivas-Santiago B, Enciso JA. Mycobacterium tuberculosis entry into mast cells through cholesterol-rich membrane microdomains. Scand J Immunol, 2009, 70(3):256-263. [11]张影,陆坚,侯志平,等.肺结核患者疗程中外周血辅助性和调节性T细胞的动态研究. 中国防痨杂志,2013,35(6): 427-432. [12]Perreau M,Rozot V,Welles HC, et al. Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease. Eur J Immunol,2013,43 (4):939-948. [13]Wozniak TM, Saunders BM, Ryan AA, et al. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect Immun,2010,78(10):4187-4194. [14]Eum SY, Kong JH, Hong MS, et al. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest,2010,137 (1):122-128. [15]Berry MP, Graham CM, McNab FW, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature, 2010, 466 (7309):973-977. [16]Wang T, Lv M, Qian Q, et al. Increased frequencies of T helper type 17 cells in tuberculous pleural effusion. Tuberculosis(Edinb),2011,91(3):231-237. [17]夏小学, 陈江, 卢火佺, 等. 抗结核治疗对肺结核病患者血清TNF-α、IFN-γ、IL-10和IL-17表达差异的影响. 中国微生态学杂志, 2013, 25(3): 306-308. [18]Matthews K, Wilkinson KA, Kalsdorf B, et al. Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis. Tuberculosis (Edinb), 2011, 91 (6):587-593. [19]Li Q, Li J, Tian J, et al. IL-17 and IFN-γ production in peripheral blood following BCG vaccination and Mycobacterium tuberculosis infection in human. Eur Rev Med Pharmacol Sci,2012,16(14):2029-2036. [20]Kumar NP, Sridhar R, Banurekha VV, et al. Expansion of pathogen-specific mono- and multifunctional Th1 and Th17 cells in multi-focal tuberculous lymphadenitis. PLoS One,2013,8(2):e57123. [21]Peters A, Lee Y, Kuchroo VK. The many faces of Th17 cells. Curr Opin Immunol, 2011,23(6):702-706. [22]Cruz A, Fraga AG, Fountain JJ, et al. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med,2010,207(8):1609-1616. [23]Marin ND, París SC, Vélez VM, et al. Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. Tuberculosis(Edinb), 2010,90(4):252-261. [24]Shafiani S, Tucker-Heard G, Kariyone A, et al.Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med,2010,207(7):1409-1420. [25]de Cassan SC, Pathan AA, Sander CR, et al. Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A. Clin Vaccine Immunol, 2010, 17 (7):1066-1073. [26]Lalor MK, Smith SG, Floyd S, et al. Complex cytokine profiles induced by BCG vaccination in UK infants. Vaccine,2010,28 (6):1635-1641. |